MERSANA THERAPEUTICS INC's ticker is MRSN and the CUSIP is 59045L106. A total of 154 filers reported holding MERSANA THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.95 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $29,337 | -61.4% | 23,100 | 0.0% | 0.00% | -75.0% |
| Q2 2023 | $75,999 | -20.0% | 23,100 | 0.0% | 0.00% | -20.0% |
| Q1 2023 | $94,941 | -29.9% | 23,100 | 0.0% | 0.01% | -37.5% |
| Q4 2022 | $135,366 | -13.2% | 23,100 | 0.0% | 0.01% | -20.0% |
| Q3 2022 | $156,000 | +45.8% | 23,100 | 0.0% | 0.01% | +66.7% |
| Q2 2022 | $107,000 | +16.3% | 23,100 | 0.0% | 0.01% | +20.0% |
| Q1 2022 | $92,000 | -36.1% | 23,100 | 0.0% | 0.01% | 0.0% |
| Q4 2021 | $144,000 | -33.9% | 23,100 | 0.0% | 0.01% | -50.0% |
| Q3 2021 | $218,000 | -30.6% | 23,100 | 0.0% | 0.01% | -37.5% |
| Q2 2021 | $314,000 | -16.0% | 23,100 | 0.0% | 0.02% | -5.9% |
| Q1 2021 | $374,000 | -46.2% | 23,100 | -11.6% | 0.02% | -45.2% |
| Q4 2020 | $695,000 | +221.8% | 26,128 | +125.5% | 0.03% | +158.3% |
| Q3 2020 | $216,000 | – | 11,589 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 4,005,600 | $64,810,000 | 6.21% |
| Bain Capital Life Sciences Investors, LLC | 3,695,667 | $59,796,000 | 3.39% |
| COMMODORE CAPITAL LP | 429,228 | $6,945,000 | 2.77% |
| ACUTA CAPITAL PARTNERS, LLC | 357,689 | $5,787,000 | 2.09% |
| Avoro Capital Advisors LLC | 6,800,000 | $110,024,000 | 1.90% |
| Ghost Tree Capital, LLC | 450,000 | $7,281,000 | 1.71% |
| RHO CAPITAL PARTNERS INC | 796,458 | $12,887,000 | 1.24% |
| Rock Springs Capital Management LP | 2,775,127 | $44,902,000 | 0.98% |
| Sio Capital Management, LLC | 157,259 | $2,544,000 | 0.52% |
| Bellevue Group AG | 2,850,010 | $46,113,000 | 0.49% |